ezetimibe has been researched along with Weight Loss in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Derdemezis, CS; Elisaf, M; Florentin, M; Liberopoulos, EN; Tellis, CC; Tselepis, A | 1 |
Barrett, PH; Chan, DC; Gan, SK; Ooi, EM; Watts, GF | 1 |
Michishita, I; Mizuguchi, I; Nozue, T; Sasaki, M; Tsunoda, T; Yamada, M | 1 |
Krone, W; Müller-Wieland, D | 1 |
1 review(s) available for ezetimibe and Weight Loss
Article | Year |
---|---|
[Hyperlipidemia: therapeutic principles in clinical practice].
Topics: Adult; Anticholesteremic Agents; Azetidines; Cardiovascular Diseases; Cholesterol, LDL; Clinical Trials as Topic; Coronary Disease; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Ezetimibe; Humans; Hyperlipidemias; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Insulin Resistance; Nutritional Physiological Phenomena; Practice Guidelines as Topic; Risk Factors; Time Factors; Weight Loss | 2003 |
2 trial(s) available for ezetimibe and Weight Loss
Article | Year |
---|---|
Effects of rimonabant, as monotherapy and in combination with fenofibrate or ezetimibe, on plasma adipokine levels: a pilot study.
Topics: Adipokines; Adult; Aged; Azetidines; Body Mass Index; Diet, Reducing; Drug Therapy, Combination; Dyslipidemias; Ezetimibe; Female; Fenofibrate; Humans; Hypolipidemic Agents; Male; Middle Aged; Obesity; Piperidines; Pyrazoles; Rimonabant; Weight Loss | 2010 |
Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss diet.
Topics: Adipokines; Aged; alpha-2-HS-Glycoprotein; Anticholesteremic Agents; Apolipoprotein B-100; Azetidines; Biomarkers; Blood Proteins; Body Composition; C-Reactive Protein; Combined Modality Therapy; Diet, Reducing; Ezetimibe; Fatty Liver; Humans; Insulin Resistance; Liver; Middle Aged; Obesity; Patient Compliance; Triglycerides; Weight Loss | 2010 |
1 other study(ies) available for ezetimibe and Weight Loss
Article | Year |
---|---|
Effects of ezetimibe on atherogenic lipoproteins and glucose metabolism in patients with diabetes and glucose intolerance.
Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Atherosclerosis; Azetidines; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Ezetimibe; Female; Follow-Up Studies; Glucose Intolerance; Glycated Hemoglobin; Homeostasis; Humans; Japan; Lipoproteins, LDL; Male; Middle Aged; Risk Factors; Treatment Outcome; Weight Loss | 2013 |